BioRem (R6D) Stock Overview

A clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds, and hazardous air pollutants. More details

R6D fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	1/6
Past Performance	2/6
Financial Health	5/6
Dividends	0/6

Rewards

Trading at 69.1% below our estimate of its fair value

Revenue is forecast to grow 19.65% per year

Risk Analysis

Profit margins (6.1%) are lower than last year (12.9%)

Does not have a meaningful market cap (€41M)

R6D Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View Stock Community

BioRem Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for BioRem
Historical stock prices
Current Share Price	CA$1.52
52 Week High	CA$1.64
52 Week Low	CA$1.09
Beta	0.58
1 Month Change	0%
3 Month Change	26.67%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	21.60%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	R6D	DE Commercial Services	DE Market
7D	-6.2%	5.9%	2.4%
1Y	n/a	67.5%	15.5%

Return vs Industry: Insufficient data to determine how R6D performed against the German Commercial Services industry.

Return vs Market: Insufficient data to determine how R6D performed against the German Market.

Price Volatility

Is R6D's price volatile compared to industry and market?
R6D volatility
R6D Average Weekly Movement	7.1%
Commercial Services Industry Average Movement	6.0%
Market Average Movement	5.1%
10% most volatile stocks in DE Market	12.1%
10% least volatile stocks in DE Market	2.5%

Stable Share Price: R6D has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: R6D's weekly volatility (7%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1990	n/a	Derek Webb	www.biorem.biz

BioRem Inc., a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds, and hazardous air pollutants. The company offers biofilters; biotrickling filters; multi-stage systems; biogas desulfurization systems; dry scrubber adsorption systems; and cannabis odor control systems. It also sells biofiltration media products under the BIOSORBENS, XLD, BIOPAK, BIOROLL, and BIOBLOK names.

BioRem Inc. Fundamentals Summary

How do BioRem's earnings and revenue compare to its market cap?
R6D fundamental statistics
Market cap	€25.39m
Earnings (TTM)	€1.30m
Revenue (TTM)	€21.45m

19.4x

P/E Ratio

1.2x

P/S Ratio

Is R6D overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
R6D income statement (TTM)
Revenue	CA$34.73m
Cost of Revenue	CA$26.31m
Gross Profit	CA$8.42m
Other Expenses	CA$6.31m
Earnings	CA$2.11m

Last Reported Earnings

Sep 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)	0.13
Gross Margin	24.25%
Net Profit Margin	6.08%
Debt/Equity Ratio	16.4%

How did R6D perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/01/09 00:38
End of Day Share Price	2026/01/09 00:00
Earnings	2025/09/30
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BioRem Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Nicholas Boychuk	Cormark Securities Inc.